Welcome to Sabbiotech!     
Email:info@signalwayantibody.com
Location: Home > Phospho Antibodies > Chk2(Phospho-Ser516) Antibody

Chk2(Phospho-Ser516) Antibody#11147

Availability: Yes
Total Amount:$
Product Detail

Product NameChk2(Phospho-Ser516) Antibody

Host SpeciesRabbit

ClonalityPolyclonal

PurificationAntibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.

ApplicationsWB

Species ReactivityHu

SpecificityThe antibody detects endogenous level of Chk2 only when phosphorylated at serine 516.

Immunogen TypePeptide-KLH

Immunogen DescPeptide sequence around phosphorylation site of serine 516 (Q-P-S(p)-T-S) derived from Human Chk2.

Target NameChk2

ConjugateUnconjugated

Other NamesCHEK2; Cds1;

Accession NoSwiss-Prot: O96017
NCBI Protein: NP_001005735.1

Uniprot O96017

Gene ID 11200;

Concentration1.0mg/ml

FormulationSupplied at 1.0mg/mL in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

StorageStore at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Application Details

Predicted MW: 62kd
Western blotting: 1:500~1:1000
 

Western blot analysis of extracts from A549 cells untreated or treated with Anisomycin using Chk2(Phospho-Ser516) Antibody #11147.

In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by Chk2 gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Three transcript variants encoding different isoforms have been found for this gene.

Wu X, Chen J et al.(2003)J Biol Chem; 278(38): 36163-8
Schwarz JK, et al.(2003)Mol Cancer Res; 1(8): 598-609
Lou Z, et al.(2003) Nature; 421(6926): 957-61
 

If you have published an article using product 11147, please notify us so that we can cite your literature.

et al,Planar compression of extracellular substrates induces S phase arrest via ATM-independent CHK2 activation.In Biochem Biophys Res Commun. On 2018 Dec 2 by Hayakawa K, Hirata H et al..PMID:30404732 , (2018),
PMID: 30404732

NOTE

Application

  • WBWestern Blotting
  • IHCImmunohistochemistry
  • IFImmunofluorescence
  • ICCImmunocytochemistry
  • FCFlow Cytometry
  • IPImmunoprecipitation
  • EELISA
  • DBDot Blotting
  • ChIPChromatin Immunoprecipitation
  • GICAGold Immunochromatography Assay
  • NCNegative Control

Species Reactivity

  • HuHuman
  • MsMouse
  • RtRat
  • DmDrosophila melanogaster
  • CCaenorhabditis elegans
  • MkMonkey
  • RbRabbit
  • BBovine
  • DDog
  • PPig
  • HmHamster
  • ChHmChinese Hamster
  • ChkChicken
  • ShpSheep
;